Dual time point [F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues.
Fiche publication
Date publication
décembre 2019
Journal
EJNMMI research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr OLIVIER Pierre, Pr COCHET Alexandre
Tous les auteurs :
Lovinfosse P, Rousseau C, Pierga JY, Bouchet F, Cochet A, Alberini JL, Girault S, Vera P, Olivier P, Uwer L, Cachin F, Scarwell B, Lemonnier J, Fourme E, Mesleard C, Martin AL, Lacœuille F, Couturier OF
Lien Pubmed
Résumé
For differentiating tumor from inflammation and normal tissues, fluorodeoxyglucose ([F]FDG) dual time point PET could be helpful. Albeit [F]FLT is more specific for tumors than [F]FDG; we explored the role of dual time point [F]FLT-PET for discriminating benign from malignant tissues.
Mots clés
Breast cancer, FLT, Fluorothymidine, Positron emission tomography
Référence
EJNMMI Res. 2019 Dec 12;9(1):109